Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Tri (Q44994543)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Tri |
scientific article |
Statements
Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial (English)
Ichiro Shintaku
Makoto Satoh
Naomasa Ioritani
Masataka Aizawa
Tatsuo Tochigi
Sadafumi Kawamura
Hiroshi Aoki
Isao Numata
Atsushi Takeda
Shunichi Namiki
Takashige Namima
Yoshihiro Ikeda
Koichi Kambe
Atsushi Kyan
Seiji Ueno
Kazuhiko Orikasa
Shinnosuke Katoh
Hisanobu Adachi
Satoru Tokuyama
Shigeto Ishidoya
Takuhiro Yamaguchi